stockrowMedtronic PLC
MDT Healthcare Medical Devices
Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025.
- Revenue
- +13.7%
- EPS
- +42.0%
- Free cash flow
- +120.9%
- Total debt
- −1.59%
Quarter to July 2026, against a year earlier
Follow MDT
Alert me
Medtronic PLC (MDT) Return on equity
Medtronic PLC's return on equity over the twelve months to 31 July 2026 was 10.6%, up 0.8 percentage points from fiscal 2026 (9.77%). Over the past ten years it has ranged from 6.14% (fiscal 2018) to 9.77% (fiscal 2026) — the current reading is the highest in ten years. That is above the Medical Devices industry median of −10.4% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2026 | 9.77% | 0.32 |
| FY2025 | 9.45% | 2.25 |
| FY2024 | 7.20% | 0.00 |
| FY2023 | 7.20% | (2.46) |
| FY2022 | 9.66% | 2.62 |
| FY2021 | 7.04% | (2.44) |
| FY2020 | 9.48% | 0.31 |
| FY2019 | 9.17% | 3.03 |
| FY2018 | 6.14% | (1.73) |
| FY2017 | 7.87% | 1.15 |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| DXCM DexCom, Inc. compare | 37.7% |
| GEHC GE HealthCare Technologies Inc. compare | 19.9% |
| SYK Stryker Corporation compare | 16.0% |
| BSX Boston Scientific Corporation compare | 14.2% |
| STE STERIS plc compare | 11.6% |
| MDT Medtronic PLC | 10.6% |
| EW Edwards Lifesciences Corporation compare | 9.65% |
| PHG Koninklijke Philips N.V. compare | 8.54% |
| ABT Abbott Laboratories compare | 0.00% |
| Medical Devices industry median | −10.4% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on MDT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement